Decentralized Clinical Trials (DCTs)

DCTs involve conducting clinical trials remotely, with participants receiving study-related services at their homes or other convenient locations, rather than traveling to a clinical research site. This shift to the patient's environment eliminates the need for frequent site visits, which can be inconvenient, time-consuming, and costly for participants.

Increased accessibility Improved patient engagement Enhanced data quality

Hybrid clinical trials combine elements of both centralized and decentralized trials. In a hybrid trial, some participants may receive study-related services at a clinical research site, while others may receive them remotely. This approach can offer the best of both worlds, potentially improving accessibility while maintaining the ability to closely monitor participants at a central location.

DCTs offer several potential benefits

Increased accessibility

Improved patient engagement

Enhanced data quality


Challenges of DCTs and Hybrid Trials

Technology infrastructure

Patient recruitment and retention

Regulatory compliance

Don't miss out on the latest updates

Be the first to hear our breaking news

  • Phone:0034 950 52 45 45  
  • Address:Res. Playas de la Ensenada, 75 – 3C. 04711 El Ejido, Almeria. Spain.  
Follow us
official account
Copyright © Caico   All rights reserved